PPI Dosing for Severe Esophageal Thickening

Initial Treatment Approach

For severe erosive esophagitis, the American Gastroenterological Association recommends initiating twice-daily PPI therapy with high-potency agents, such as esomeprazole 40 mg or rabeprazole 40 mg twice daily, taken 30-60 minutes before meals for 4-8 weeks, as severe erosive esophagitis and complications require more aggressive acid suppression than standard once-daily dosing 1, 2
Severe esophageal disease requires higher-dose PPI therapy from the outset, with standard once-daily dosing being insufficient for severe erosive esophagitis or complications like stricture formation 1, 3

The American Gastroenterological Association notes that not all PPIs are equivalent in acid-suppressing potency, with esomeprazole 20 mg being equivalent to rabeprazole 20 mg, and lansoprazole 30 mg being equivalent to 27 mg omeprazole equivalent 4
For severe disease, esomeprazole or rabeprazole at 20-40 mg twice daily are recommended over other agents due to their higher potency 4, 2

The American Gastroenterological Association recommends that patients with severe erosive esophagitis require continuous maintenance therapy, with daily PPI therapy being mandatory as recurrence rates approach 80% at one year without maintenance 1, 3
Maintenance dosing can often be reduced to once-daily therapy after initial healing, with omeprazole 20 mg, lansoprazole 30 mg, or equivalent being suitable options 2

For esophageal thickening due to eosinophilic esophagitis, PPIs are first-line pharmacologic therapy, with 61% clinical response and 51% histologic remission rates 1, 3
These patients should never be considered for PPI de-prescribing due to high recurrence rates and risk of fibrotic stricture formation 1, 3